Viewing Study NCT03654703


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2026-02-25 @ 8:49 PM
Study NCT ID: NCT03654703
Status: UNKNOWN
Last Update Posted: 2018-08-31
First Post: 2018-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML
Sponsor: Capital Research Institute of Pediatrics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematopoietic System--Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HSCT, AML, R-AML View